Barclays raised the firm’s price target on Clorox to $130 from $122 and keeps an Underweight rating on the shares following the fiscal Q4 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox (CLX) Declares Q3 Dividend: Important Details for Shareholders
- Clorox reports Q4 gross margin up 380 bps to 46.5% from 42.7% last year
- Clorox Reports Q4 and FY24 Results, Provides FY25 Outlook
- Clorox sees FY25 adjusted EPS $6.55-$6.80, consensus $6.45
- Clorox reports Q4 adjusted EPS $1.82, consensus $1.56